Skip to content
2000
image of Bridging Gaps in Long COVID Therapy: A Review
file format pdf download PDF

Abstract

Introduction

Long COVID-19 (LC) is a condition that follows SARS-CoV-2, an acute infection defined by persistent fatigue, dyspnea, and impaired cognitive function. LC presents a complex array that imposes ongoing challenges on global health, patients' quality of life, and functional capacity. Many inconsistencies surround its pathophysiology, diagnosis, prevention, and treatment. This review aims to cover missed gaps in LC with a special focus on therapeutic strategies concerning non-pharmacological, pharmacological, experimental, and innovative approaches for better patient management and outcomes, as well as to evaluate their effectiveness and guide future research.

Methods

An online search was conducted using five digital repositories: PubMed, Scopus, Google Scholar, Web of Science, and the Cochrane Library. A combination of keywords associated with LC therapy was employed: “long COVID, “pharmacological options,” “non-pharmacological options,” “innovative strategies,” “experimental”, and” quality of life (QOL).” Relevant data were extracted and synthesized to categorize therapeutic approaches into subtypes. A critical analysis was conducted on their mechanism of action, indication, outcome, and limitations.

Results

The pooled prevalence of LC was 42%, and the symptom duration ranged from 3 months to 2 years. The most important risk factors for LC were female sex, unvaccinated status, and cases with co-morbidities. Diagnosis of LC was challenging due to a lack of diagnostic standardization and reliable biomarkers.

Discussion

Non-pharmacological strategies were employed first, showing diverse efficacies; however, the reported literature was hindered by small sampling. Pharmacological agents show promising results but need further validation. Experimental and innovative strategies need longer studies and validations.

Conclusion

LC has imposed a significant burden on community health, necessitating the appropriate allocation of health resources and community support. Preventive and therapeutic interventions show promise, but the variability in patient response underscores the need for personalized approaches and more well-designed trials. Collaborative research and multi-disciplinary teams are needed to mitigate the long-term effects of LC and improve patient outcomes.

© 2025 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673389691250709181809
2025-07-30
2025-11-04

  • From This Site

    /content/journals/cmc/10.2174/0109298673389691250709181809
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cmc/10.2174/0109298673389691250709181809/BMS-CMC-2025-98.html?itemId=/content/journals/cmc/10.2174/0109298673389691250709181809&mimeType=html&fmt=ahah

References

  1. Ngongolo K. Impacts, mitigation strategies of COVID-19 on human well-being in Africa: A brief review. Soc. Sci. Humanit. Open 2023 8 1 100709 10.1016/j.ssaho.2023.100709
    [Google Scholar]
  2. Edwards F. Hamilton F.W. Impact of COVID-19 vaccination on long covid. BMJ Med. 2023 2 1 e000470 10.1136/bmjmed‑2022‑000470 36936263
    [Google Scholar]
  3. Sohrabi C. Mathew G. Franchi T. Kerwan A. Griffin M. Soleil C Del Mundo J. Ali S.A. Agha M. Agha R. Impact of the coronavirus (COVID-19) pandemic on scientific research and implications for clinical academic training – A review. Int. J. Surg. 2021 86 57 63 10.1016/j.ijsu.2020.12.008
    [Google Scholar]
  4. Alkodaymi M.S. Omrani O.A. Ashraf N. Shaar B.A. Almamlouk R. Riaz M. Obeidat M. Obeidat Y. Gerberi D. Taha R.M. Kashour Z. Kashour T. Berbari E.F. Alkattan K. Tleyjeh I.M. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2022 28 5 657 666 10.1016/j.cmi.2022.01.014 35124265
    [Google Scholar]
  5. O’Mahoney L.L. Routen A. Gillies C. Ekezie W. Welford A. Zhang A. Karamchandani U. Simms-Williams N. Cassambai S. Ardavani A. Wilkinson T.J. Hawthorne G. Curtis F. Kingsnorth A.P. Almaqhawi A. Ward T. Ayoubkhani D. Banerjee A. Calvert M. Shafran R. Stephenson T. Sterne J. Ward H. Evans R.A. Zaccardi F. Wright S. Khunti K. The prevalence and long-term health effects of Long COVID among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine 2023 55 101762 10.1016/j.eclinm.2022.101762 36474804
    [Google Scholar]
  6. Healey Q. Sheikh A. Daines L. Vasileiou E. Symptoms and signs of long COVID: A rapid review and meta-analysis. J. Glob. Health 2022 12 05014 10.7189/jogh.12.05014 35596571
    [Google Scholar]
  7. A clinical case definition of post COVID-19 condition by a Delphi consensus. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 2021
  8. Notarte K.I. de Oliveira M.H.S. Peligro P.J. Velasco J.V. Macaranas I. Ver A.T. Pangilinan F.C. Pastrana A. Goldrich N. Kavteladze D. Gellaco M.M.L. Liu J. Lippi G. Henry B.M. Fernández-de-las-Peñas C. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: A systematic review and meta-analysis. J. Clin. Med. 2022 11 24 7314 10.3390/jcm11247314 36555931
    [Google Scholar]
  9. Muthuka J.K. Nzioki J.M. Kelly J.O. Musangi E.N. Chebungei L.C. Nabaweesi R. Kiptoo M.K. Prevalence and predictors of long COVID-19 and the average time to diagnosis in the general population: A systematic review, meta-analysis and meta-regression. COVID 2024 4 7 968 981 10.3390/covid4070067
    [Google Scholar]
  10. Huerne K. Filion K.B. Grad R. Ernst P. Gershon A.S. Eisenberg M.J. Epidemiological and clinical perspectives of long COVID syndrome. Am. J. Med. Open 2023 9 100033 10.1016/j.ajmo.2023.100033 36685609
    [Google Scholar]
  11. Romero-Ibarguengoitia M.E. Rodríguez-Torres J.F. Garza-Silva A. Rivera-Cavazos A. Morales-Rodriguez D.P. Hurtado-Cabrera M. Kalife-Assad R. Villarreal-Parra D. Loose-Esparza A. Gutiérrez-Arias J.J. Mata-Porras Y.G. Ojeda-Salazar D.A. Sanz-Sánchez M.A. González-Cantú A. Azzolini E. Rescigno M. Association of vaccine status, reinfections, and risk factors with Long COVID syndrome. Sci. Rep. 2024 14 1 2817 10.1038/s41598‑024‑52925‑4 38307886
    [Google Scholar]
  12. Adnan A. New-onset diabetic ketoacidosis precipitated by COVID-19 in children:A case report. Kirkuk J. Med. Sci. 2022 10 1 98 103 10.32894/kjms.2022.174188
    [Google Scholar]
  13. Iqbal F.M. Lam K. Sounderajah V. Clarke J.M. Ashrafian H. Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine 2021 36 100899 10.1016/j.eclinm.2021.100899 34036253
    [Google Scholar]
  14. Su Y. Yuan D. Chen D.G. Ng R.H. Wang K. Choi J. Li S. Hong S. Zhang R. Xie J. Kornilov S.A. Scherler K. Pavlovitch-Bedzyk A.J. Dong S. Lausted C. Lee I. Fallen S. Dai C.L. Baloni P. Smith B. Duvvuri V.R. Anderson K.G. Li J. Yang F. Duncombe C.J. McCulloch D.J. Rostomily C. Troisch P. Zhou J. Mackay S. DeGottardi Q. May D.H. Taniguchi R. Gittelman R.M. Klinger M. Snyder T.M. Roper R. Wojciechowska G. Murray K. Edmark R. Evans S. Jones L. Zhou Y. Rowen L. Liu R. Chour W. Algren H.A. Berrington W.R. Wallick J.A. Cochran R.A. Micikas M.E. Wrin T. Petropoulos C.J. Cole H.R. Fischer T.D. Wei W. Hoon D.S.B. Price N.D. Subramanian N. Hill J.A. Hadlock J. Magis A.T. Ribas A. Lanier L.L. Boyd S.D. Bluestone J.A. Chu H. Hood L. Gottardo R. Greenberg P.D. Davis M.M. Goldman J.D. Heath J.R. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022 185 5 881 895.e20 10.1016/j.cell.2022.01.014 35216672
    [Google Scholar]
  15. Opsteen S. Files J.K. Fram T. Erdmann N. The role of immune activation and antigen persistence in acute and long COVID. J. Investig. Med. 2023 71 5 545 562 10.1177/10815589231158041 36879504
    [Google Scholar]
  16. Mihai C.M. Chisnoiu T. Balasa A.L. Frecus C.E. Mihai L. Pantazi A.C. Clinical characteristics and laboratory findings in children with multisystem inflammatory syndrome (MIS-C)—A retrospective study of a tertiary care center from Constanta, Romania. Healthc 2023 11 4 544 10.3390/healthcare11040544 36833078
    [Google Scholar]
  17. Akram N.N. Ibrahim B.A. Ali S.M. Nori W. Clinical and laboratory characteristics of children with neurological presentations of COVID-19: A single-center experience. J. Med. Life 2022 15 10 1294 1298 10.25122/jml‑2022‑0184 36420294
    [Google Scholar]
  18. Georgieva E. Ananiev J. Yovchev Y. Arabadzhiev G. Abrashev H. Abrasheva D. Atanasov V. Kostandieva R. Mitev M. Petkova-Parlapanska K. Karamalakova Y. Koleva-Korkelia I. Tsoneva V. Nikolova G. COVID-19 complications: Oxidative stress, inflammation, and mitochondrial and endothelial dysfunction. Int. J. Mol. Sci. 2023 24 19 14876 10.3390/ijms241914876 37834324
    [Google Scholar]
  19. Smadja D.M. Mentzer S.J. Fontenay M. Laffan M.A. Ackermann M. Helms J. Jonigk D. Chocron R. Pier G.B. Gendron N. Pons S. Diehl J.L. Margadant C. Guerin C. Huijbers E.J.M. Philippe A. Chapuis N. Nowak-Sliwinska P. Karagiannidis C. Sanchez O. Kümpers P. Skurnik D. Randi A.M. Griffioen A.W. COVID-19 is a systemic vascular hemopathy: Insight for mechanistic and clinical aspects. Angiogenesis 2021 24 4 755 788 10.1007/s10456‑021‑09805‑6 34184164
    [Google Scholar]
  20. Jammoul M. Naddour J. Madi A. Reslan M.A. Hatoum F. Zeineddine J. Abou-Kheir W. Lawand N. Investigating the possible mechanisms of autonomic dysfunction post-COVID-19. Auton. Neurosci. 2023 245 103071 10.1016/j.autneu.2022.103071 36580747
    [Google Scholar]
  21. Goldstein D.S. Post-COVID dysautonomias: What we know and (mainly) what we don’t know. Nat. Rev. Neurol. 2024 20 2 99 113 10.1038/s41582‑023‑00917‑9 38212633
    [Google Scholar]
  22. Leitner B.P. Joseph P. Quast A.F. Ramirez M.A. Heerdt P.M. Villalobos J.G. Singh I. The metabolic and physiologic impairments underlying long COVID associated exercise intolerance. Pulm. Circ. 2024 14 4 e70009 10.1002/pul2.70009 39544193
    [Google Scholar]
  23. Zhang D. Zhou Y. Ma Y. Chen P. Tang J. Yang B. Li H. Liang M. Xue Y. Liu Y. Zhang J. Wang X. Gut microbiota dysbiosis correlates with long COVID-19 at one-year after discharge. J. Korean Med. Sci. 2023 38 15 e120 10.3346/jkms.2023.38.e120 37069814
    [Google Scholar]
  24. Bai F. Tomasoni D. Falcinella C. Barbanotti D. Castoldi R. Mulè G. Augello M. Mondatore D. Allegrini M. Cona A. Tesoro D. Tagliaferri G. Viganò O. Suardi E. Tincati C. Beringheli T. Varisco B. Battistini C.L. Piscopo K. Vegni E. Tavelli A. Terzoni S. Marchetti G. Monforte A.A. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2022 28 4 611.e9 611.e16 10.1016/j.cmi.2021.11.002 34763058
    [Google Scholar]
  25. Krüger S. Long-COVID: Vaccination and early antiviral therapy reduce the risk. Compass Pneumol 2023 11 2 73 74 10.1159/000530014
    [Google Scholar]
  26. Atchison C.J. Davies B. Cooper E. Lound A. Whitaker M. Hampshire A. Azor A. Donnelly C.A. Chadeau-Hyam M. Cooke G.S. Ward H. Elliott P. Long-term health impacts of COVID-19 among 242,712 adults in England. Nat. Commun. 2023 14 1 6588 10.1038/s41467‑023‑41879‑2 37875536
    [Google Scholar]
  27. Akram N.N. Nori W. Al Qaissi K.W. Abdulrahman Hadi B.A. Multi-systemic inflammatory syndrome in childhood (MIS-C): A review article. J. Pak. Med. Assoc. 2021 71 12 S70 S73 35130265
    [Google Scholar]
  28. Bridger Staatz C. Bann D. Ploubidis G.B. Goodman A. Silverwood R.J. Age of first overweight and obesity, COVID-19 and long COVID in two british birth cohorts. J. Epidemiol. Glob. Health 2023 13 1 140 153 10.1007/s44197‑023‑00093‑5 36811824
    [Google Scholar]
  29. Tsampasian V. Elghazaly H. Chattopadhyay R. Debski M. Naing T.K.P. Garg P. Clark A. Ntatsaki E. Vassiliou V.S. Risk factors associated with post−COVID-19 condition. JAMA Intern. Med. 2023 183 6 566 580 10.1001/jamainternmed.2023.0750 36951832
    [Google Scholar]
  30. Song Z. Giuriato M. Demographic and clinical factors associated with long COVID. Health Aff. 2023 42 3 433 442 10.1377/hlthaff.2022.00991 36877912
    [Google Scholar]
  31. Nadhmi S. The manifestation of COVID-19 virus in children in Kirkuk city. Kirkuk J Med Sci 2021 10 9 1 204 217 10.32894/kjms.2021.169938
    [Google Scholar]
  32. Costea D. Serbanescu L. Badiu D. Ardeleanu V. Branescu C. Zgura A. Costea A. Pain management in the right iliac fossa during the COVID-19 pandemic. J. Mind Med. Sci. 2022 9 1 162 167 10.22543/7674.91.P162167
    [Google Scholar]
  33. Ceban F. Kulzhabayeva D. Rodrigues N.B. Di Vincenzo J.D. Gill H. Subramaniapillai M. Lui L.M.W. Cao B. Mansur R.B. Ho R.C. Burke M.J. Rhee T.G. Rosenblat J.D. McIntyre R.S. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis. Brain Behav. Immun. 2023 111 211 229 10.1016/j.bbi.2023.03.022
    [Google Scholar]
  34. Nori W. Ghani Zghair M.A. Omicron targets upper airways in pediatrics, elderly and unvaccinated population. World J. Clin. Cases 2022 10 32 12062 12065 10.12998/wjcc.v10.i32.12062 36405264
    [Google Scholar]
  35. Fuller T. Flores Mamani R. Ferreira Pinto Santos H. Melo Espíndola O. Guaraldo L. Lopes Melo C. Borges Da Silva M.F. Amaral Calvet G. Soares Bastos L. Carvalho M.S. Brasil P. Sex, vaccination status, and comorbidities influence long COVID persistence. J. Infect. Public Health 2024 17 11 102562 10.1016/j.jiph.2024.102562 39418956
    [Google Scholar]
  36. Jeffrey K. Hammersley V. Maini R. Crawford A. Woolford L. Batchelor A. Weatherill D. White C. Millington T. Kerr R. Basetti S. Macdonald C. Quint J.K. Kerr S. Shah S.A. Kurdi A. Simpson C.R. Katikireddi S.V. Rudan I. Robertson C. Ritchie L. Sheikh A. Daines L. Deriving and validating a risk prediction model for long COVID: A population-based, retrospective cohort study in Scotland. J. R. Soc. Med. 2024 117 12 402 414 10.1177/01410768241297833 39556251
    [Google Scholar]
  37. Azzam A. Khaled H. Refaey N. Mohsen S. El-Emam O.A. Dawood N. Ahmed H.A. Soliman O.A. Mostafa S. Ramadan H. Mosa M. Elmowafy A.O.I. Rizk S.M.A. Zaki A. Hussien M. Ahmed A. Ezzat A.A. Hassan F.E. The burden of persistent symptoms after COVID-19 (long COVID): A meta-analysis of controlled studies in children and adults. Virol. J. 2024 21 1 16 10.1186/s12985‑024‑02284‑3 38212781
    [Google Scholar]
  38. Davis H.E. McCorkell L. Vogel J.M. Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023 21 3 133 146 10.1038/s41579‑022‑00846‑2
    [Google Scholar]
  39. Ray J.G. Schull M.J. Vermeulen M.J. Park A.L. Association between abo and rh blood groups and SARS-COV-2 infection or severe COVID-19 illness. Ann. Intern. Med. 2021 174 3 308 315 10.7326/M20‑4511
    [Google Scholar]
  40. Rabiee Rad M. Abbasi M. Salimian E. Norouzi M. Emamjomeh A. Haghighatdoost F. Mahmoudi S. Najafian J. Masoudi S. Ghasempour Dabaghi G. Mohammadifard N. Sarrafzadegan N. Baseline socioeconomic status predicting post-COVID-19 symptoms: Results from Isfahan COVID Cohort (ICC) study. Prev. Med. Rep. 2024 45 102814 10.1016/j.pmedr.2024.102814 39070708
    [Google Scholar]
  41. Jeong Y.K. Kim H.Y. Symptom clusters and quality of life in people with long COVID: A cross-sectional online survey. J Korean Acad Fundam Nurs 2024 31 3 326 337 10.7739/jkafn.2024.31.3.326
    [Google Scholar]
  42. Beurnier A. Savale L. Jaïs X. Colle R. Pham T. Morin L. Bulifon S. Noël N. Boucly A. Delbarre B. Ebstein N. Figueiredo S. Gasnier M. Harrois A. Jutant E.M. Jevnikar M. Keddache S. Lecoq A.L. Meyrignac O. Parent F. Pichon J. Preda M. Roche A. Seferian A. Bellin M.F. Gille T. Corruble E. Sitbon O. Becquemont L. Monnet X. Humbert M. Montani D. Morin L. Savale L. Pham T. Colle R. Figueiredo S. Harrois A. Gasnier M. Lecoq A-L. Meyrignac O. Noel N. Baudry E. Bellin M-F. Beurnier A. Choucha W. Corruble E. Dortet L. Hardy-Leger I. Radiguer F. Sportouch S. Verny C. Wyplosz B. Zaidan M. Becquemont L. Montani D. Monnet X. Functional respiratory complaints among COVID-19 survivors: A prospective cohort study. ERJ Open Res. 2023 9 3 00063-2023 10.1183/23120541.00063‑2023 37131523
    [Google Scholar]
  43. Kusumawardhani N.Y. Putra I.C.S. Kamarullah W. Afrianti R. Pramudyo M. Iqbal M. Prameswari H.S. Achmad C. Tiksnadi B.B. Akbar M.R. Cardiovascular disease in post-acute COVID-19 syndrome: A comprehensive review of pathophysiology and diagnosis approach. Rev. Cardiovasc. Med. 2023 24 1 28 10.31083/j.rcm2401028 39076856
    [Google Scholar]
  44. Liu E.N. Yang J.H. Patel L. Arora J. Gooding A. Ellis R. Graves J.S. Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19. J. Neurol. 2023 270 10 4661 4672 10.1007/s00415‑023‑11885‑x 37493802
    [Google Scholar]
  45. Parums D.V. Long COVID or post-acute sequelae of SARS-CoV-2 infection (PASC) and the urgent need to identify diagnostic biomarkers and risk factors. Med. Sci. Monit. 2024 30 e946512 10.12659/MSM.946512 39289865
    [Google Scholar]
  46. Sharma S.K. Mohan A. Upadhyay V. Long COVID syndrome: An unfolding enigma. Indian J. Med. Res. 2024 159 6 585 600 10.25259/IJMR_1449_23 39382470
    [Google Scholar]
  47. O’ Mahony L. Buwalda T. Blair M. Forde B. Lunjani N. Ambikan A. Neogi U. Barrett P. Geary E. O’Connor N. Dineen J. Clarke G. Kelleher E. Horgan M. Jackson A. Sadlier C. Impact of Long COVID on health and quality of life. HRB Open Res. 2022 5 31 10.12688/hrbopenres.13516.1 36101871
    [Google Scholar]
  48. Antar A.A.R. Cox A.L. Translating insights into therapies for Long COVID. Sci. Transl. Med. 2024 16 773 eado2106 10.1126/scitranslmed.ado2106 39536116
    [Google Scholar]
  49. Szewczyk W. Fitzpatrick A.L. Fossou H. Gentile N.L. Sotoodehnia N. Vora S.B. West T.E. Bertolli J. Cope J.R. Lin J.M.S. Unger E.R. Vu Q.M. Long COVID and recovery from Long COVID: Quality of life impairments and subjective cognitive decline at a median of 2 years after initial infection. BMC Infect. Dis. 2024 24 1 1241 10.1186/s12879‑024‑10158‑w 39497076
    [Google Scholar]
  50. Zaidi A.K. Dehgani-Mobaraki P. Long Covid. Prog. Mol. Biol. Transl. Sci. 2024 202 113 125 10.1016/bs.pmbts.2023.11.002 38237983
    [Google Scholar]
  51. Tsilingiris D. Vallianou N.G. Karampela I. Christodoulatos G.S. Papavasileiou G. Petropoulou D. Magkos F. Dalamaga M. Laboratory findings and biomarkers in Long COVID: What do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and challenges. Int. J. Mol. Sci. 2023 24 13 10458 10.3390/ijms241310458 37445634
    [Google Scholar]
  52. Nori W. Hameed B.H. Thamir A.R. Fadhil A. COVID-19 in pregnancy: Implication on platelets and blood indices. Rev. Bras. Ginecol. Obstet. 2021 43 8 595 599 10.1055/s‑0041‑1733912 34547793
    [Google Scholar]
  53. Lai Y.J. Liu S.H. Manachevakul S. Lee T.A. Kuo C.T. Bello D. Biomarkers in long COVID-19: A systematic review. Front. Med 2023 10 1085988 10.3389/fmed.2023.1085988 36744129
    [Google Scholar]
  54. Klein J. Wood J. Jaycox J.R. Dhodapkar R.M. Lu P. Gehlhausen J.R. Tabachnikova A. Greene K. Tabacof L. Malik A.A. Silva Monteiro V. Silva J. Kamath K. Zhang M. Dhal A. Ott I.M. Valle G. Peña-Hernández M. Mao T. Bhattacharjee B. Takahashi T. Lucas C. Song E. McCarthy D. Breyman E. Tosto-Mancuso J. Dai Y. Perotti E. Akduman K. Tzeng T.J. Xu L. Geraghty A.C. Monje M. Yildirim I. Shon J. Medzhitov R. Lutchmansingh D. Possick J.D. Kaminski N. Omer S.B. Krumholz H.M. Guan L. Dela Cruz C.S. van Dijk D. Ring A.M. Putrino D. Iwasaki A. Distinguishing features of long COVID identified through immune profiling. Nature 2023 623 7985 139 148 10.1038/s41586‑023‑06651‑y 37748514
    [Google Scholar]
  55. Antoniou K.M. Vasarmidi E. Russell A.M. Andrejak C. Crestani B. Delcroix M. Dinh-Xuan A.T. Poletti V. Sverzellati N. Vitacca M. Witzenrath M. Tonia T. Spanevello A. European respiratory society statement on long COVID follow-up. Eur. Respir. J. 2022 60 2 2102174 10.1183/13993003.02174‑2021 35144991
    [Google Scholar]
  56. Abdulqader S.K. Ali S.S.M. Fadhil A.A. Akram N.N. Hassan W.N.M. Impact of Vaccination Status on Chest CT Findings and Disease Outcomes in COVID-19 Era: A Retrospective Study. Coronaviruses 2024 6 1 73 81 10.2174/0126667975315612240425074611
    [Google Scholar]
  57. Stoian M. Roman A. Boeriu A. Onișor D. Bandila S.R. Babă D.F. Cocuz I. Niculescu R. Costan A. Laszlo S.Ș. Corău D. Stoian A. Long-term radiological pulmonary changes in mechanically ventilated patients with respiratory failure due to SARS-CoV-2 infection. Biomedicines 2023 11 10 2637 10.3390/biomedicines11102637 37893011
    [Google Scholar]
  58. Liu K. Zhang W. Yang Y. Zhang J. Li Y. Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement. Ther. Clin. Pract. 2020 39 101166 10.1016/j.ctcp.2020.101166 32379637
    [Google Scholar]
  59. Rotz S.J. Bhatt N.S. Hamilton B.K. Duncan C. Aljurf M. Atsuta Y. Beebe K. Buchbinder D. Burkhard P. Carpenter P.A. Chaudhri N. Elemary M. Elsawy M. Guilcher G.M.T. Hamad N. Karduss A. Peric Z. Purtill D. Rizzo D. Rodrigues M. Ostriz M.B.R. Salooja N. Schoemans H. Seber A. Sharma A. Srivastava A. Stewart S.K. Baker K.S. Majhail N.S. Phelan R. International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: A 2023 update. Transplant. Cell. Ther. 2024 30 4 349 385 10.1016/j.jtct.2023.12.001 38413247
    [Google Scholar]
  60. Gyöngyösi M. Alcaide P. Asselbergs F.W. Brundel B.J.J.M. Camici G.G. Martins P.C. Ferdinandy P. Fontana M. Girao H. Gnecchi M. Gollmann-Tepeköylü C. Kleinbongard P. Krieg T. Madonna R. Paillard M. Pantazis A. Perrino C. Pesce M. Schiattarella G.G. Sluijter J.P.G. Steffens S. Tschöpe C. Van Linthout S. Davidson S.M. Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: A joint scientific statement of the ESC working groups on cellular biology of the heart and myocardial and pericardial diseases. Cardiovasc. Res. 2023 119 2 336 356 10.1093/cvr/cvac115 35875883
    [Google Scholar]
  61. Machado F.V.C. Meys R. Delbressine J.M. Vaes A.W. Goërtz Y.M.J. van Herck M. Houben-Wilke S. Boon G.J.A.M. Barco S. Burtin C. van ’t Hul A. Posthuma R. Franssen F.M.E. Spies Y. Vijlbrief H. Pitta F. Rezek S.A. Janssen D.J.A. Siegerink B. Klok F.A. Spruit M.A. Construct validity of the post-COVID-19 functional status scale in adult subjects with COVID-19. Health Qual. Life Outcomes 2021 19 1 40 10.1186/s12955‑021‑01691‑2 33536042
    [Google Scholar]
  62. Jacobs L.G. Paleoudis E.G. Bari D.L. Di Nyirenda T. Friedman T. Gupta A. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One 2020 15 12 e0243882 10.1371/journal.pone.0243882 33306721
    [Google Scholar]
  63. Peluso M.J. Deeks S.G. Mechanisms of long COVID and the path toward therapeutics. Cell 2024 187 20 5500 5529 10.1016/j.cell.2024.07.054 39326415
    [Google Scholar]
  64. Azzolini E. Levi R. Sarti R. Pozzi C. Mollura M. Mantovani A. Rescigno M. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA 2022 328 7 676 678 10.1001/jama.2022.11691 35796131
    [Google Scholar]
  65. Català M. Mercadé-Besora N. Kolde R. Trinh N.T.H. Roel E. Burn E. Rathod-Mistry T. Kostka K. Man W.Y. Delmestri A. Nordeng H.M.E. Uusküla A. Duarte-Salles T. Prieto-Alhambra D. Jödicke A.M. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: Staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir. Med. 2024 12 3 225 236 10.1016/S2213‑2600(23)00414‑9 38219763
    [Google Scholar]
  66. Domènech-Montoliu S. Puig-Barberà J. Badenes-Marques G. Gil-Fortuño M. Orrico-Sánchez A. Pac-Sa M.R. Perez-Olaso O. Sala-Trull D. Sánchez-Urbano M. Arnedo-Pena A. Long COVID prevalence and the impact of the third SARS-CoV-2 vaccine dose: A cross-sectional analysis from the third follow-up of the borriana cohort, Valencia, Spain (2020–2022). Vaccines 2023 11 10 1590 10.3390/vaccines11101590 37896992
    [Google Scholar]
  67. Lotfi H. Mazar M.G. Ei N.M.H. Fahim M. Yazdi N.S. Vaccination is the most effective and best way to avoid the disease of COVID-19. Immun. Inflamm. Dis. 2023 11 8 e946 10.1002/iid3.946 37647441
    [Google Scholar]
  68. Bielecka-Dabrowa A. Sakowicz A. Gryglewska-Wawrzak K. Kapusta J. Banach M. Jankowski P. Chudzik M. The effect of sex on the risk of long- COVID and cardiovascular complications in healthy patients without comorbidities: Data from a polish long- COVID cardiovascular (PoLoCOV-CVD) study. J. Clin. Med. 2024 13 6 1559 10.3390/jcm13061559 38541785
    [Google Scholar]
  69. Chandan J.S. Brown K.R. Simms-Williams N. Bashir N.Z. Camaradou J. Heining D. Turner G.M. Rivera S.C. Hotham R. Minhas S. Nirantharakumar K. Sivan M. Khunti K. Raindi D. Marwaha S. Hughes S.E. McMullan C. Marshall T. Calvert M.J. Haroon S. Aiyegbusi O.L. TLC Study Non-pharmacological therapies for post-viral syndromes, including Long COVID: A systematic review. Int. J. Environ. Res. Public Health 2023 20 4 3477 10.3390/ijerph20043477 36834176
    [Google Scholar]
  70. Nori W. Kassim M.A.K. Helmi Z.R. Pantazi A.C. Brezeanu D. Brezeanu A.M. Penciu R.C. Serbanescu L. Non-pharmacological pain management in labor: A systematic review. J. Clin. Med. 2023 12 23 7203 10.3390/jcm12237203 38068274
    [Google Scholar]
  71. Chandan J.S. Brown K. Simms-Williams N. Camaradou J. Bashir N. Heining D. Aiyegbusi O.L. Turner G. Cruz Rivera S. Hotham R. Nirantharakumar K. Sivan M. Khunti K. Raindi D. Marwaha S. Hughes S.E. McMullan C. Calvert M. Haroon S. Non-pharmacological therapies for postviral syndromes, including Long COVID: A systematic review and meta-analysis protocol. BMJ Open 2022 12 4 e057885 10.1136/bmjopen‑2021‑057885 35410933
    [Google Scholar]
  72. Fine J.S. Ambrose A.F. Didehbani N. Fleming T.K. Glashan L. Longo M. Merlino A. Ng R. Nora G.J. Rolin S. Silver J.K. Terzic C.M. Verduzco-Gutierrez M. Sampsel S. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R 2022 14 1 96 111 10.1002/pmrj.12745 34902226
    [Google Scholar]
  73. Desai A.D. Boursiquot B.C. Melki L. Wan E.Y. Management of arrhythmias associated with COVID-19. Curr. Cardiol. Rep. 2021 23 1 2 10.1007/s11886‑020‑01434‑7 33231782
    [Google Scholar]
  74. Knotkova H. Hamani C. Sivanesan E. Le Beuffe M.F.E. Moon J.Y. Cohen S.P. Huntoon M.A. Neuromodulation for chronic pain. Lancet 2021 397 10289 2111 2124 10.1016/S0140‑6736(21)00794‑7 34062145
    [Google Scholar]
  75. Seo J.W. Kim S.E. Kim Y. Kim E.J. Kim T. Kim T. Lee S.H. Lee E. Lee J. Seo Y.B. Jeong Y.H. Jung Y.H. Choi Y.J. Song J.Y. Updated clinical practice guidelines for the diagnosis and management of long COVID. Infect. Chemother. 2024 56 1 122 157 10.3947/ic.2024.0024 38527781
    [Google Scholar]
  76. Kuut T.A. Müller F. Csorba I. Braamse A. Aldenkamp A. Appelman B. Assmann-Schuilwerve E. Geerlings S.E. Gibney K.B. Kanaan R.A.A. Mooij-Kalverda K. Olde Hartman T.C. Pauëlsen D. Prins M. Slieker K. van Vugt M. Keijmel S.P. Nieuwkerk P. Rovers C.P. Knoop H. Efficacy of cognitive-behavioral therapy targeting severe fatigue following coronavirus disease 2019: Results of a randomized controlled trial. Clin. Infect. Dis. 2023 77 5 687 695 10.1093/cid/ciad257 37155736
    [Google Scholar]
  77. Kassim M.A.K. Pantazi A.C. Nori W. Tuta L.A. Balasa A.L. Mihai C.M. Mihai L. Frecus C.E. Lupu V.V. Lupu A. Andrusca A. Iorga A.M. Litrin R.M. Ion I. Ciciu E. Chirila S.I. Chisnoiu T. Non-pharmacological interventions for pain management in hemodialysis: A narrative review. J. Clin. Med. 2023 12 16 5390 10.3390/jcm12165390 37629432
    [Google Scholar]
  78. Zhuang W. Fan Z. Chu Y. Wang H. Yang Y. Wu L. Sun N. Sun G. Shen Y. Lin X. Guo G. Chinese patent medicines in the treatment of coronavirus disease 2019 (COVID-19) in China. Front Pharmacol 2020 11 1066 10.3389/fphar.2020.01066 32848729
    [Google Scholar]
  79. Nori W. Akram N.N. Al-Kaabi M.M. Probiotics in women and pediatrics health: A narrative review. Al-Anbar Med. J. 2023 19 1 10 16 10.33091/amj.2023.138442.1021
    [Google Scholar]
  80. Bachmeier B.E. Hölzle S. Gasser M. van den Akker M. How do German General Practitioners Manage Long-/Post-COVID? A Qualitative Study in Primary Care. Viruses 2023 15 4 1016 10.3390/v15041016 37112996
    [Google Scholar]
  81. Wang C.C. Lo J. Saunders R. Adama E. Bulsara C. Etherton-Beer C. Yang A.W.H. Light acupuncture and five-element music therapy for nurses’ mental health and well-being during and post-COVID-19: Protocol for a randomised cross-over feasibility study. BMJ Open 2022 12 4 e057106 10.1136/bmjopen‑2021‑057106
    [Google Scholar]
  82. Lam W.C. Wei D. Li H. Yao L. Zhang S. Lai M.X.Y. Zheng Y. Yeung J.W.F. Lau A.Y.L. Lyu A. Bian Z. Cheung A.M. Zhong L.L.D. The use of acupuncture for addressing neurological and neuropsychiatric symptoms in patients with long COVID: A systematic review and meta-analysis. Front. Neurol. 2024 15 1406475 10.3389/fneur.2024.1406475 39099786
    [Google Scholar]
  83. Robbins T. Gonevski M. Clark C. Baitule S. Sharma K. Magar A. Hyperbaric oxygen therapy for the treatment of long COVID: Early evaluation of a highly promising intervention. Clin Med 2021 21 6 e629 e632 10.7861/clinmed.2021‑0462 34862223
    [Google Scholar]
  84. Gawey B. Yang J. Bauer B. Song J. Wang X.J. The use of complementary and alternative medicine for the treatment of gastrointestinal symptoms in Long COVID: A systematic review. Ther. Adv. Chronic Dis. 2023 14 20406223231190548 10.1177/20406223231190548 37577106
    [Google Scholar]
  85. Shah K. Varna V.P. Sharma U. Mavalankar D. Does vitamin D supplementation reduce COVID-19 severity?: A systematic review. QJM 2022 115 10 665 672 10.1093/qjmed/hcac040 35166850
    [Google Scholar]
  86. Bradbury J. Wilkinson S. Schloss J. Nutritional support during long COVID: A systematic scoping review. J. Integr. Complement. Med. 2023 29 11 695 704 10.1089/jicm.2022.0821 37102680
    [Google Scholar]
  87. Alenazy M.F. Aljohar H.I. Alruwaili A.R. Daghestani M.H. Alonazi M.A. Labban R.S. El-Ansary A.K. Balto H.A. Gut microbiota dynamics in relation to long- COVID-19 syndrome: Role of probiotics to combat psychiatric complications. Metabolites 2022 12 10 912 10.3390/metabo12100912 36295814
    [Google Scholar]
  88. Pantazi A.C. Kassim M.A.K. Nori W. Tuta L.A. Mihai C.M. Chisnoiu T. Balasa A.L. Mihai L. Lupu A. Frecus C.E. Lupu V.V. Chirila S.I. Badescu A.G. Hangan L.T. Cambrea S.C. Clinical perspectives of gut microbiota in patients with chronic kidney disease and end-stage kidney disease: Where do we stand? Biomedicines 2023 11 9 2480 10.3390/biomedicines11092480 37760920
    [Google Scholar]
  89. Choi Y.J. Seo Y.B. Seo J.W. Lee J. Nham E. Seong H. Yoon J.G. Noh J.Y. Cheong H.J. Kim W.J. Kim E.J. Song J.Y. Effectiveness of anti-viral therapy on long COVID: A systematic review and meta-analysis. J. Clin. Med. 2023 12 23 7375 10.3390/jcm12237375 38068427
    [Google Scholar]
  90. Goel N. Goyal N. Nagaraja R. Kumar R. Systemic corticosteroids for management of ‘long-COVID’: An evaluation after 3 months of treatment. Monaldi Arch. Chest Dis. 2021 92 2 10.4081/monaldi.2021.1981 34730322
    [Google Scholar]
  91. Glynne P. Tahmasebi N. Gant V. Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2022 70 1 61 67 10.1136/jim‑2021‑002051 34611034
    [Google Scholar]
  92. Bonilla H. Peluso M.J. Rodgers K. Aberg J.A. Patterson T.F. Tamburro R. Baizer L. Goldman J.D. Rouphael N. Deitchman A. Fine J. Fontelo P. Kim A.Y. Shaw G. Stratford J. Ceger P. Costantine M.M. Fisher L. O’Brien L. Maughan C. Quigley J.G. Gabbay V. Mohandas S. Williams D. McComsey G.A. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative. Front. Immunol. 2023 14 1129459 10.3389/fimmu.2023.1129459 36969241
    [Google Scholar]
  93. Sun G. Lin K. Ai J. Zhang W. The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: A systematic review and meta-analysis. Clin Microbiol Infect 2024 30 12 1505 1513 10.1016/j.cmi.2024.07.006 39002665
    [Google Scholar]
  94. Nobile B. Durand M. Olié E. Guillaume S. Molès J.P. Haffen E. Courtet P. The anti-inflammatory effect of the tricyclic antidepressant clomipramine and its high penetration in the brain might be useful to prevent the psychiatric consequences of SARS-CoV-2 infection. Front. Pharmacol. 2021 12 615695 10.3389/fphar.2021.615695 33767623
    [Google Scholar]
  95. Farahani R.H. Ajam A. Naeini A.R. Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial. BMC Infect. Dis. 2023 23 1 197 10.1186/s12879‑023‑08172‑5 37003990
    [Google Scholar]
  96. Stefanou M.I. Palaiodimou L. Bakola E. Smyrnis N. Papadopoulou M. Paraskevas G.P. Rizos E. Boutati E. Grigoriadis N. Krogias C. Giannopoulos S. Tsiodras S. Gaga M. Tsivgoulis G. Neurological manifestations of long-COVID syndrome: A narrative review. Ther. Adv. Chronic Dis. 2022 13 20406223221076890 10.1177/20406223221076890 35198136
    [Google Scholar]
  97. Wang S.S.Y. Xu C. Hydroxychloroquine: Is there a role in long COVID? Clin. Rheumatol. 2023 42 3 977 978 10.1007/s10067‑023‑06514‑x 36695924
    [Google Scholar]
  98. Nori W. Akram N.N. Al-Ani R.M. Update on hydroxychloroquine use in pregnancy. World J. Exp. Med. 2023 13 4 99 101 10.5493/wjem.v13.i4.99 37767540
    [Google Scholar]
  99. McCarthy M.W. Intravenous immunoglobulin as a potential treatment for long COVID. Expert Opin. Biol. Ther. 2023 23 12 1211 1217 10.1080/14712598.2023.2296569 38100573
    [Google Scholar]
  100. Rizk J.G. Kalantar-Zadeh K. Mehra M.R. Lavie C.J. Rizk Y. Forthal D.N. Pharmaco-immunomodulatory therapy in COVID-19. Drugs 2020 80 13 1267 1292 10.1007/s40265‑020‑01367‑z 32696108
    [Google Scholar]
  101. Zhang X. Shang L. Fan G. Gu X. Xu J. Wang Y. Huang L. Cao B. The efficacy and safety of janus kinase inhibitors for patients with COVID-19: A living systematic review and meta-analysis. Front. Med 2022 8 800492 10.3389/fmed.2021.800492 35155477
    [Google Scholar]
  102. Bramante C.T. Beckman K.B. Mehta T. Karger A.B. Odde D.J. Tignanelli C.J. Buse J.B. Johnson D.M. Watson R.H.B. Daniel J.J. Liebovitz D.M. Nicklas J.M. Cohen K. Puskarich M.A. Belani H.K. Siegel L.K. Klatt N.R. Anderson B. Hartman K.M. Rao V. Hagen A.A. Patel B. Fenno S.L. Avula N. Reddy N.V. Erickson S.M. Fricton R.D. Lee S. Griffiths G. Pullen M.F. Thompson J.L. Sherwood N.E. Murray T.A. Rose M.R. Boulware D.R. Huling J.D. Anderson B. Atwater R.C. Avula N. Beckman K.B. Belani H.K. Boulware D.R. Bramante C.T. Brea J. Broedlow C.A. Buse J.B. Campora P. Challa A. Charles J. Christensen G. Christiansen T. Cohen K. Connelly B. Datta S. Deng N. Dunn A.T. Erickson S.M. Fairbairn F.M. Fenno S.L. Fraser D.J. Fricton R.D. Griffiths G. Hagen A.A. Hartman K.M. Hendrickson A.F. Huling J.D. Ingraham N.E. Jeng A.C. Johnson D.M. Karger A.B. Klatt N.R. Kuehl E.A. LaBar D.D. Lee S. Liebovitz D.M. Lindberg S. Luke D.G. Machicado R. Mohamud Z. Murray T.A. Ngonyama R. Nicklas J.M. Odde D.J. Parrens E. Parra D. Patel B. Proper J.L. Pullen M.F. Puskarich M.A. Rao V. Reddy N.V. Reddy N. Rypka K.J. Saveraid H.G. Seloadji P. Shahriar A. Sherwood N. Siegart J.L. Siegel L.K. Simmons L. Sinelli I. Singh P. Snyder A. Stauffer M.T. Thompson J. Tignanelli C.J. Tople T.L. Tordsen W.J. Watson R.H.B. Wu B. Zaman A. Zolik M.R. Zinkl L. Favorable antiviral effect of metformin on SARS-CoV-2 viral load in a randomized, placebo-controlled clinical trial of COVID-19. Clin. Infect. Dis. 2024 79 2 354 363 10.1093/cid/ciae159 38690892
    [Google Scholar]
  103. Achleitner M. Steenblock C. Dänhardt J. Jarzebska N. Kardashi R. Kanczkowski W. Straube R. Rodionov R.N. Bornstein N. Tselmin S. Kaiser F. Bucher R. Barbir M. Wong M.L. Voit-Bak K. Licinio J. Bornstein S.R. Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis. Mol. Psychiatry 2023 28 7 2872 2877 10.1038/s41380‑023‑02084‑1 37131073
    [Google Scholar]
  104. Proal A.D. Aleman S. Bomsel M. Brodin P. Buggert M. Cherry S. Chertow D.S. Davies H.E. Dupont C.L. Deeks S.G. Ely E.W. Fasano A. Freire M. Geng L.N. Griffin D.E. Henrich T.J. Hewitt S.M. Iwasaki A. Krumholz H.M. Locci M. Marconi V.C. Mehandru S. Muller-Trutwin M. Painter M.M. Pretorius E. Price D.A. Putrino D. Qian Y. Roan N.R. Salmon D. Tan G.S. VanElzakker M.B. Wherry E.J. Van Weyenbergh J. Yonker L.M. Peluso M.J. Targeting the SARS-CoV-2 reservoir in long COVID. Lancet Infect. Dis. 2025 25 5 e294 e306 10.1016/S1473‑3099(24)00769‑2 39947217
    [Google Scholar]
  105. Cimellaro A. Addesi D. Cavallo M. Spagnolo F. Suraci E. Cordaro R. Spinelli I. Passafaro F. Colosimo M. Pintaudi M. Pintaudi C. Monoclonal antibodies and antivirals against SARS-CoV-2 reduce the risk of long COVID: A retrospective propensity score-matched case–control study. Biomedicines 2022 10 12 3135 10.3390/biomedicines10123135 36551891
    [Google Scholar]
  106. Baz M. Baker B. Kumar P. Lange U. Livieratos A. Gogos C. Beyond antivirals: Alternative therapies for long COVID. Viruses 2024 16 11 1795 10.3390/v16111795
    [Google Scholar]
  107. Tang Y. Zou X. Liu P. Dai Y. Wang S. Su X. Yu Y. Tang W. Zhou J. Li C. Mei H. Xiao N. Ou Y. Wang J. Lu G. Lin G. Cheng L. Human umbilical cord-derived mesenchymal stem cell transplantation improves the long COVID. J. Med. Virol. 2024 96 6 e29757 10.1002/jmv.29757 38899432
    [Google Scholar]
  108. Castle R.D. Williams M.A. Bushell W.C. Rindfleisch J.A. Peterson C.T. Marzolf J. Brouwer K. Mills P.J. Implications for systemic approaches to COVID-19: Effect sizes of remdesivir, tocilizumab, melatonin, vitamin d3, and meditation. J. Inflamm. Res. 2021 14 4859 4876 10.2147/JIR.S323356 34588793
    [Google Scholar]
  109. Cardinali D.P. Brown G.M. Pandi-Perumal S.R. Possible application of melatonin in long COVID. Biomolecules 2022 12 11 1646 10.3390/biom12111646 36358996
    [Google Scholar]
  110. Carlile O. Briggs A. Henderson A.D. Butler-Cole B.F.C. Tazare J. Tomlinson L.A. Marks M. Jit M. Lin L.Y. Bates C. Parry J. Bacon S.C.J. Dillingham I. Dennison W.A. Costello R.E. Walker A.J. Hulme W. Goldacre B. Mehrkar A. MacKenna B. Walker A. Green A. Mehrkar A. Schaffer A. Brown A. Goldacre B. Butler-Cole B. MacKenna B. Morton C. Walters C. Stables C. Cunningham C. Wood C. Andrews C. Evans D. Hickman G. Curtis H. Drysdale H. Dillingham I. Morley J. Massey J. Nab L. Hopcroft L. Fisher L. Bridges L. Wiedemann M. DeVito N. Macdonald O. Inglesby P. Smith R. Croker R. Park R. Higgins R. Bacon S. Davy S. Maude S. O’Dwyer T. Ward T. Speed V. Hulme W. Hart L. Stokes P. Bhaskaran K. Costello R. Cowling T. Douglas I. Eggo R. Evans S. Forbes H. Grieve R. Grint D. Herrett E. Langan S. Mahalingasivam V. Mansfield K. Mathur R. McDonald H. Parker E. Rentsch C. Schultze A. Smeeth L. Tazare J. Tomlinson L. Walker J. Williamson E. Wing K. Wong A. Zheng B. Bates C. Cockburn J. Parry J. Hester F. Harper S. O’Hanlon S. Eavis A. Jarvis R. Avramov D. Griffiths P. Fowles A. Parkes N. Perera R. Harrison D. Khunti K. Sterne J. Quint J. Herrett E. Eggo R.M. Impact of long COVID on health-related quality-of-life: An OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT). Lancet Reg. Health Eur. 2024 40 100908 10.1016/j.lanepe.2024.100908 38689605
    [Google Scholar]
  111. Sisó-Almirall A. Brito-Zerón P. Conangla Ferrín L. Kostov B. Moragas Moreno A. Mestres J. Sellarès J. Galindo G. Morera R. Basora J. Trilla A. Ramos- Casals M. Long COVID-19: Proposed primary care clinical guidelines for diagnosis and disease management. Int. J. Environ. Res. Public Health 2021 18 8 4350 10.3390/ijerph18084350 33923972
    [Google Scholar]
  112. Sapna F.N.U. Deepa F.N.U. Sakshi F.N.U. Sonam F.N.U. Kiran F.N.U. Perkash R.S. Bendari A. Kumar A. Rizvi Y. Suraksha F.N.U. Varrassi G. Unveiling the mysteries of long COVID syndrome: Exploring the distinct tissue and organ pathologies linked to prolonged COVID-19 symptoms. Cureus 2023 15 9 e44588 10.7759/cureus.44588 37795061
    [Google Scholar]
  113. Zang C. Hou Y. Schenck E.J. Xu Z. Zhang Y. Xu J. Bian J. Morozyuk D. Khullar D. Nordvig A.S. Shenkman E.A. Rothman R.L. Block J.P. Lyman K. Zhang Y. Varma J. Weiner M.G. Carton T.W. Wang F. Kaushal R. Identification of risk factors of Long COVID and predictive modeling in the RECOVER EHR cohorts. Commun. Med. 2024 4 1 130 10.1038/s43856‑024‑00549‑0 38992068
    [Google Scholar]
  114. Maglietta G. Diodati F. Puntoni M. Lazzarelli S. Marcomini B. Patrizi L. Caminiti C. Prognostic factors for post-COVID-19 syndrome: A systematic review and meta- analysis. J. Clin. Med. 2022 11 6 1541 10.3390/jcm11061541 35329867
    [Google Scholar]
  115. Mohammedain S.A. Badran S. Elzouki A.Y. Salim H. Chalaby A. Siddiqui M.Y.A. Hussein Y.Y. Rahim H.A. Thalib L. Alam M.F. Al-Badriyeh D. Al- Maadeed S. Doi S.A.R. Validation of a risk prediction model for COVID-19: The PERIL prospective cohort study. Future Virol. 2023 18 15 991 999 10.2217/fvl‑2023‑0036 37970094
    [Google Scholar]
  116. Tang C.C. Wu W.W. Ho S.J. Liu W.D. Pan M.Y. Chang S.C. Wang W.S. Yeh Y.C. Chen C.H. Chang J.C. Clinically significant functional impairments and symptoms in COVID-19 survivors: Empirical research quantitative. J. Clin. Nurs. 2025 jocn.17715 10.1111/jocn.17715 40084807
    [Google Scholar]
  117. Halpin S.J. McIvor C. Whyatt G. Adams A. Harvey O. McLean L. Walshaw C. Kemp S. Corrado J. Singh R. Collins T. O’Connor R.J. Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021 93 2 1013 1022 10.1002/jmv.26368 32729939
    [Google Scholar]
  118. Huang L. Yao Q. Gu X. Wang Q. Ren L. Wang Y. Hu P. Guo L. Liu M. Xu J. Zhang X. Qu Y. Fan Y. Li X. Li C. Yu T. Xia J. Wei M. Chen L. Li Y. Xiao F. Liu D. Wang J. Wang X. Cao B. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet 2021 398 10302 747 758 10.1016/S0140‑6736(21)01755‑4 34454673
    [Google Scholar]
  119. Tenforde M.W. Kim S.S. Lindsell C.J. Billig Rose E. Shapiro N.I. Files D.C. Gibbs K.W. Erickson H.L. Steingrub J.S. Smithline H.A. Gong M.N. Aboodi M.S. Exline M.C. Henning D.J. Wilson J.G. Khan A. Qadir N. Brown S.M. Peltan I.D. Rice T.W. Hager D.N. Ginde A.A. Stubblefield W.B. Patel M.M. Self W.H. Feldstein L.R. Hart K.W. McClellan R. Dorough L. Dzuris N. Griggs E.P. Kassem A.M. Marcet P.L. Ogokeh C.E. Sciarratta C.N. Siddula A. Smith E.R. Wu M.J. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March–June 2020. MMWR Morb. Mortal. Wkly. Rep. 2020 69 30 993 998 10.15585/mmwr.mm6930e1 32730238
    [Google Scholar]
  120. Goërtz Y.M.J. Van Herck M. Delbressine J.M. Vaes A.W. Meys R. Machado F.V.C. Houben-Wilke S. Burtin C. Posthuma R. Franssen F.M.E. van Loon N. Hajian B. Spies Y. Vijlbrief H. van ’t Hul A.J. Janssen D.J.A. Spruit M.A. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020 6 4 00542-2020 10.1183/23120541.00542‑2020 33257910
    [Google Scholar]
  121. Hopkins C. Surda P. Whitehead E. Kumar B.N. Early recovery following new onset anosmia during the COVID-19 pandemic – An observational cohort study. J. Otolaryngol. Head Neck Surg. 2020 49 1 26 10.1186/s40463‑020‑00423‑8 32366299
    [Google Scholar]
  122. Carfì A. Bernabei R. Landi F. Persistent symptoms in patients after acute COVID-19. JAMA 2020 324 6 603 605 10.1001/jama.2020.12603 32644129
    [Google Scholar]
  123. Sutherland S. Long COVID now looks like a neurological disease, helping doctors to focus treatments. Available from: https://www.scientificamerican.com/article/long-covid-now-looks-like-a-neurological-disease-helping-doctors-to-focus-treatments1/ 2023
  124. Rathod N. Jr Kumar S. Chavhan R. Acharya S. Rathod S. Rathod N. Navigating the long haul: A comprehensive review of long-COVID sequelae, patient impact, pathogenesis, and management. Cureus 2024 16 5 e60176 10.7759/cureus.60176 38868283
    [Google Scholar]
  125. Reiss A.B. Greene C. Dayaramani C. Rauchman S.H. Stecker M.M. De Leon J. Pinkhasov A. Long COVID, the brain, nerves, and cognitive function. Neurol. Int. 2023 15 3 821 841 10.3390/neurolint15030052 37489358
    [Google Scholar]
  126. Whitaker-Hardin B. McGregor K.M. Uswatte G. Lokken K. A narrative review of the efficacy of long COVID interventions on brain fog, processing speed, and other related cognitive outcomes. Biomedicines 2025 13 2 421 10.3390/biomedicines13020421 40002834
    [Google Scholar]
  127. Sousa N.M.F. Maranhão A.C.P.F. Braga L.W. Cognitive impairment and neuropsychiatric symptoms among individuals with history of symptomatic SARS-CoV-2 infection: A retrospective longitudinal study. Dement. Neuropsychol. 2024 18 e20230053 10.1590/1980‑5764‑dn‑2023‑0053 38425703
    [Google Scholar]
  128. Fashkhami M.N. Mohammadi S.P. The effectiveness of cognitive rehabilitation in improving working memory and attention in acute COVID-19 survivors. Shahroud J Med Sci 2024 10 2 29 36 10.22100/ijhs.v10i2.1097
    [Google Scholar]
  129. Dong Y. Ritto A.P. Damiano R.F. Coli A.G. Hadade R. Rocca C.C.A. Serafim A.P. Guedes B.F. Nitrini R. Imamura M. Forlenza O.V. Busatto Filho G. Memory complaints after COVID-19: A potential indicator of primary cognitive impairment or a correlate of psychiatric symptoms? Transl. Psychiatry 2024 14 1 455 10.1038/s41398‑024‑03154‑w 39461945
    [Google Scholar]
  130. Talkington G.M. Kolluru P. Gressett T.E. Ismael S. Meenakshi U. Acquarone M. Solch-Ottaiano R.J. White A. Ouvrier B. Paré K. Parker N. Watters A. Siddeeque N. Sullivan B. Ganguli N. Calero-Hernandez V. Hall G. Longo M. Bix G.J. Neurological sequelae of long COVID: A comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics. Front. Neurol. 2025 15 1465787 10.3389/fneur.2024.1465787 40046430
    [Google Scholar]
  131. Forero K. Buqaileh R. Sunderman C. AbouAlaiwi W. COVID-19 and neurological manifestations. Brain Sci. 2023 13 8 1137 10.3390/brainsci13081137 37626493
    [Google Scholar]
  132. Jarrott B. Head R. Pringle K.G. Lumbers E.R. Martin J.H. “LONG COVID”—A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol. Res. Perspect. 2022 10 1 e00911 10.1002/prp2.911 35029046
    [Google Scholar]
  133. Aldhawyan A.F. Evaluating the predictors of persistent long COVID symptoms and their severity in COVID-19 survivors 1 year after infection. J. Prim. Care Community Health 2024 15 21501319241295686 10.1177/21501319241295686 39471195
    [Google Scholar]
  134. Gennaro F.D. Veronese N. Segala F.V. Frallonardo L. Guido G. Cormio M. Romita G. Parisi A. Marrone E. Ciuppa M.E. Carrubba A.L. Carruba L. Licata A. Cavallaro G. Pagliuso V. Maino T. Lollo S. Latino L. Solimeo L.T. Ianniello A. Montalbò D. Bavaro D.F. Fiorella M.L. Barbagallo M. Saracino A. Protective role of vaccination on the development of long COVID: Data from a large, multicenter, prospective cohort study. BMC Infect. Dis. 2024 24 1 1313 10.1186/s12879‑024‑10226‑1 38649892
    [Google Scholar]
  135. McKibbin W. Fernando R. The global economic impacts of the COVID-19 pandemic. Econ. Model. 2023 129 106551 10.1016/j.econmod.2023.106551
    [Google Scholar]
  136. Liu Y. Gu X. Li H. Zhang H. Xu J. Mechanisms of long COVID: An updated review. Chin. Med. J. Pulm. Crit. Care Med. 2023 1 4 231 240 10.1016/j.pccm.2023.10.003 39171285
    [Google Scholar]
  137. Sookaromdee P. Wiwanitkit V. Impact of COVID-19 pandemic on vertical transmission of HIV in an endemic area in indochina: A preliminary report. Mustansiriya Med. J. 2024 23 1 51 52 10.4103/mj.mj_57_23
    [Google Scholar]
  138. Serapide F. Talarico M. Rotundo S. Pascale V. Serraino R. Trecarichi E.M. Russo A. Lights and shadows of long COVID: Are latent infections the real hidden enemy? J. Clin. Med. 2024 13 23 7124 10.3390/jcm13237124 39685583
    [Google Scholar]
  139. Phillips S. Williams M.A. Re-framing Long COVID as central nervous system dysfunction. Science Insights 2024 44 6 1397 1402 10.15354/si.24.vp055
    [Google Scholar]
  140. Wong A.C. Devason A.S. Umana I.C. Cox T.O. Dohnalová L. Litichevskiy L. Perla J. Lundgren P. Etwebi Z. Izzo L.T. Kim J. Tetlak M. Descamps H.C. Park S.L. Wisser S. McKnight A.D. Pardy R.D. Kim J. Blank N. Patel S. Thum K. Mason S. Beltra J.C. Michieletto M.F. Ngiow S.F. Miller B.M. Liou M.J. Madhu B. Dmitrieva-Posocco O. Huber A.S. Hewins P. Petucci C. Chu C.P. Baraniecki-Zwil G. Giron L.B. Baxter A.E. Greenplate A.R. Kearns C. Montone K. Litzky L.A. Feldman M. Henao-Mejia J. Striepen B. Ramage H. Jurado K.A. Wellen K.E. O’Doherty U. Abdel-Mohsen M. Landay A.L. Keshavarzian A. Henrich T.J. Deeks S.G. Peluso M.J. Meyer N.J. Wherry E.J. Abramoff B.A. Cherry S. Thaiss C.A. Levy M. Serotonin reduction in post-acute sequelae of viral infection. Cell 2023 186 22 4851 4867.e20 10.1016/j.cell.2023.09.013 37848036
    [Google Scholar]
  141. Joffe A.R. Elliott A. Long COVID as a functional somatic symptom disorder caused by abnormally precise prior expectations during Bayesian perceptual processing: A new hypothesis and implications for pandemic response. SAGE Open Med. 2023 11 20503121231194400 10.1177/20503121231194400 37655303
    [Google Scholar]
  142. Celiker F.B. Kanat A. Turan A. Beyazal M. Burakgazi G. Hursoy N. Gundogdu H. Polat H.B. Could the cerebral involvement of COVID-19 disease be related to microstructural changes that are not reflected in conventional MRI images? Neurol. India 2023 71 4 699 704 10.4103/0028‑3886.383878 37635501
    [Google Scholar]
  143. Ali E.A. Salman D.A. Nori W. C-reactive protein in elderly and pregnant COVID-19 cases: A new role for an old marker. Mustansiriya Med. J. 2022 21 2 114 118 10.4103/mj.mj_54_22
    [Google Scholar]
  144. Li G. Hilgenfeld R. Whitley R. De Clercq E. Therapeutic strategies for COVID-19: Progress and lessons learned. Nat. Rev. Drug Discov. 2023 22 6 449 475 10.1038/s41573‑023‑00672‑y 37076602
    [Google Scholar]
  145. Nori W. Fadhil A. Jaafar Z.A.A. The impact of the coronavirus pandemic on telemedicine evolution in obstetrical care during COVID-19. Coronaviruses 2024 6 10.2174/0126667975363969241210093406
    [Google Scholar]
  146. Catania V. Rundo F. Panerai S. Ferri R. Virtual reality for the rehabilitation of acquired cognitive disorders: A narrative review. Bioengineering 2023 11 1 35 10.3390/bioengineering11010035 38247912
    [Google Scholar]
  147. Naidu S.B. Shah A.J. Saigal A. Smith C. Brill S.E. Goldring J. Hurst J.R. Jarvis H. Lipman M. Mandal S. The high mental health burden of “Long COVID” and its association with on-going physical and respiratory symptoms in all adults discharged from hospital. Eur. Respir. J. 2021 57 6 2004364 10.1183/13993003.04364‑2020 33795319
    [Google Scholar]
  148. Sadeghizadeh-Yazdi J. Miri T. Mozaffari Nejad A.S. COVID-19 pandemic and food safety concerns: The impact of extra-heating on chemical toxins. J. Food Qual. Hazards Control 2024 11 2 69 70 10.18502/jfqhc.11.2.15645
    [Google Scholar]
  149. Shahgolzari M. Yavari A. Arjeini Y. Miri S.M. Darabi A. Mozaffari Nejad A.S. Keshavarz M. Immunopathology and immunopathogenesis of COVID-19, what we know and what we should learn. Gene Rep. 2021 25 101417 10.1016/j.genrep.2021.101417 34778602
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673389691250709181809
Loading
Bridging Gaps in Long COVID Therapy: A Review
Bentham Science Publishers ; https://doi.org/10.2174/0109298673389691250709181809
/content/journals/cmc/10.2174/0109298673389691250709181809
/content/journals/cmc/10.2174/0109298673389691250709181809
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: pharmacological options ; biomarkers ; non-pharmacological options ; Long COVID-19 ; Google scholar ; SARS-CoV-2

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test